Founded in 2012, we are focused on researching, developing, and commercializing breakthrough medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors.
With our multi-disciplinary experience in engineering, material science, oncology, medical science, regulatory, finance, business development, sales, marketing, and clinical study coordination we are staffed with the talent to drive the next level of technology for personalized healthcare in oncology.
Location: Canada, Nova Scotia, Halifax
Employees: 11-50
Total raised: $60M
Founded date: 2012
Investors 2
| Date | Name | Website |
| - | F-Prime Ca... | fprimecapi... |
| - | Eight Road... | eightroads... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.12.2022 | Series C | $30M | - |
| 08.04.2019 | Series B | $30M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 08.12.2022 | Canada-based ABK Biomedical raises USD 30 million in oversub... | Canada-based innovative medical device company, ABK Biomedical, raised USD 30 million in recent fina... | vcbay.news... |
| 07.12.2022 | ABK Biomedical Raises USD30M in Series C Financing | ABK Biomedical, a Halifax, Canada-based medical device company, raised USD30M in Series C funding. T... | finsmes.co... |
| 06.12.2022 | ABK Biomedical Raises USD 30M in Series C Financing | - | fprimecapi... |
| 08.04.2019 | ABK Biomedical Raises $30M in Series B Financing | - | fprimecapi... |
| 08.04.2019 | ABK Biomedical Raises $30M in Series B Funding | ABK Biomedical, Inc., a Halifax, Nova Scotia, Canada-based medical device company dedicated to the r... | finsmes.co... |
| 08.04.2019 | Daily funding roundup - April 8th, 2019 | Simudyne raised $6M; Jebbit landed $12M; VSCO secured $15M; RiskLens received $20.6M Budbee: Budbee ... | vator.tv/n... |
| - | ABK Biomedical | “At ABK biomedical, we are focused on developing novel Y90 radioembolization treatment options for p... | fastfounde... |